Redcare Pharmacy N.V.（SAEYY）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · SAEYY · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$2.82B	$2.37B	$1.80B	$1.20B	$1.06B
Cost of Revenue	$2.25B	$1.82B	$1.36B	$0.87B	$0.79B
Gross Profit	$0.57B	$0.55B	$0.44B	$0.33B	$0.27B
Gross Margin %(computed)	20.19%	23.02%	24.48%	27.55%	25.14%
Operating Expenses
R&D Expenses	$0.00B	$0.00B	$0.00B	$0.00B	$0.00B
G&A Expenses	$0.05B	$0.08B	$0.03B	$0.03B	$0.02B
Total Operating Expenses	$0.59B	$0.58B	$0.46B	$0.40B	$0.31B
Operating Income	($0.02B)	($0.04B)	($0.02B)	($0.07B)	($0.07B)
Operating Margin %(computed)	-0.81%	-1.64%	-0.96%	-5.74%	-6.20%
Interest Income	$0.00B	$0.01B	$0.00B	$0.00B	$0.00B
Interest Expense	$0.02B	$0.01B	$0.02B	$0.01B	$0.01B
Income Before Tax	($0.05B)	($0.05B)	($0.01B)	($0.08B)	($0.08B)
Income Tax Expense	($0.01B)	($0.00B)	($0.00B)	($0.01B)	($0.00B)
Net Income	($0.04B)	($0.05B)	($0.01B)	($0.08B)	($0.07B)
Net Margin %(computed)	-1.28%	-1.92%	-0.67%	-6.45%	-7.00%
Per Share & EBITDA
EPS (Basic)	$-0.18	$-0.23	$-0.06	$-0.43	$-0.41
Wtd Avg Shares	0.20B	0.20B	0.19B	0.18B	0.18B
EBITDA	$0.04B	($0.01B)	$0.05B	($0.03B)	($0.04B)
EBITDA Margin %(computed)	1.55%	-0.54%	2.83%	-2.54%	-3.53%